medic rf result reflect singular long-term
return portfolio construct
strong share perform continu variou busi ader deltek
neptun verathon exampl medic segment deliv organ growth
solid organ outlook net market
share adjust sunquest fcf/ni fcf/ani
two-year compound-annual-growth-rate alreadi strong expand run rate
acquisit pipelin remain activ alway expect acquisit
remain end market agnost priorit pipelin prospect profil cash
return invest manag fit busi characterist market share
recur revenu order guidanc includ dilut divestitur
vs cumul net interest save
adj ep rose y-o-i beat estim
consensu guidanc adj sale grew y-o-i
organ acquisit fx vs estim segment om
bp y-o-i beat estim adj op rose vs
roper establish adjust ep guidanc prior consensu
organ growth adj ep guidanc
compar prior in-lin estim manag expect scientif
imag sale close gatan slate guidanc includ
month
guidanc includ organ growth medic rf rf segment
ebitda softwar expect segment report realign
ahead result orient intern oper report chang
better group busi model across enterpris
organ outlook flat/- lsd industri reflect tough
upstream comparison note slower activ amidst industri paus
saw improv market pace sentiment januari anchor guidanc
decemb sentiment upstream subsector mid/down favor
rais ep lower ep
slightli lower revenu run rate time divestitur pt
remain base ep fcf-per-share compar
expect steadi capit alloc
year price histori
roper oper busi design
develop softwar engin
product solut varieti
food energi water educ
analyst certif import disclosur see disclosur
remain attract long-term opportun attract
persist organ growth serv market high
qualiti portfolio busi rop strong posit
solid balanc sheet cash flow outlook allow
compound flexibl capit opportunist acquisit
robust gener solid convers deal pipelin
secur scientif imag backlog rate medic solut
organ outlook support solid
upsid oper leverag softwar acquisit growth
larger deal past year look favor vs deal case
acceler perform deal close cyclic exposur
inabl execut deal flow expect
price target target ep fcf-per-share compar expect steadi capit alloc price
target impli upsid potenti includ dividend yield
risk achiev price target medic growth underperform toll busi lumpi pend slower deal flow record
deal activ notwithstand pay debt
exhibit segment result varianc opco estim
loss disc ops/oth adj
compani report oppenheim co inc estim
report adjust ep vs year ago compar
consensu guidanc adjust revenu grew y-o-i
organ acq fx vs estim adjust segment margin expand
bp y-o-i beat estim adjust gross margin widen bp y-o-i
guidanc manag establish ep guidanc vs prior in-lin
organ outlook first-quart adjust ep guidanc compar prior
flow/bal sheet end cash net debt/capit vs
end net leverag vs year-end vs
estim cfo/ani fcf/ani
compani report oppenheim co inc estim
rf technolog sale
revenu increas y-o-i organ acquisit round vs
estim driven broadli across group softwar busi strong adjust om expand
bp y-o-i vs estim
manag expect organ growth segment continu strength softwar
busi improv toll traffic
medic solut sale
revenu increas y-o-i organ fx vs estim driven
strength medic product busi medic applic softwar busi om
flat y-o-i vs estim
manag expect organ growth mid-single-digit growth across medic
busi segment pro forma pend divestitur
industri technolog sale
revenu increas y-o-i organ fx round vs estim
driven continu strength neptun industri om expand bp y-o-i vs
manag expect low-single-digit organ growth growth neptun industri
busi difficult comp upstream
energi system control sale
revenu increas y-o-i organ fx vs estim slower
season ramp due tepid upstream sentiment exit om expand bp
y-o-i vs estim
manag expect flat-to-slightli lower organ growth ccc recoveri continu
upstream face difficult comp
annual sale profit segment
earn continu oper
loss discontinu operations/oth
compani report oppenheim co inc estim
quarterli sale profit segment
earn continu oper
loss disc ops/oth adj
compani report oppenheim co inc estim
analysi oper
segment revenu
total segment revenu
segment profit
total segment profit
compani report oppenheim co inc estim
year end decemb million
good sold
earn continu oper
loss discontinu operations/oth
compani report oppenheim co inc estim
sale
earn continu oper
loss disc ops/oth adj
year end decemb million
current portion long term debt
average day inventori day hand
compani report oppenheim co inc estim
consolid statement flow
year end decemb million
depreci pp
goodwil transit impair net tax
dispos busi
net chang work capit
busi acquisit net acquir
proce note payabl lt debt
princip pmt note payabl lt debt
issuanc common stock
increas dec
equival -b
equival -e
compani report oppenheim co inc estim
